NeoGenomics NEO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$99.21M-27.9% | -$108.03M-37.2% | -$113.47M-46.0% | -$104.04M-32.5% | -$77.59M+7.9% | ||
| $35.49M-8.0% | $36.07M-7.7% | $37.14M-4.4% | $37.96M-1.6% | $38.56M+0.7% | ||
| $40.2M+44.0% | $41.32M+65.6% | $41.6M+76.2% | $31.3M+32.6% | $27.92M+36.4% | ||
| $22.42M— | $5.23M— | $13.69M— | —— | —— | ||
| $27.51M-31.2% | $27.01M-34.2% | $30.74M-15.8% | $33.22M+10.8% | $39.98M+63.8% | ||
| -$20.9M— | -$12.34M— | —— | —— | —— | ||
| —— | —— | —— | -$199.62M-3,487% | $4.78M+19.7% | ||
| -$209.45M-1,567% | -$216.79M-984% | -$207.27M-472% | -$200.36M-404% | $14.28M-74.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does NeoGenomics generate?
- NeoGenomics (NEO) generated $22.4M in operating cash flow over the trailing twelve months.
- What is NeoGenomics's free cash flow?
- After $27.5M of capital expenditures, NeoGenomics's free cash flow was -$51.3M over the trailing twelve months, down 19.8% year over year.
- Where does NeoGenomics's cash flow data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
